Zhenhua M. Li

1E Lower Kent Ridge Road, Tower Block Level 12
Singapore, 119228, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 19, 2025

The Genomic Architecture of Human DNA Replication Origins.

The Genomic Architecture of Human DNA Replication Origins.

Journal: bioRxiv : the preprint server for biology

Published: December 15, 2025

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Journal: Blood

Published: December 30, 2024

Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome.

Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome.

Journal: Nature communications

Published: December 11, 2024

Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia.

Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 05, 2024

Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia.

Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia.

Journal: Nature communications

Published: July 30, 2024

DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.

DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.

Journal: Blood

Published: July 08, 2024

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.

Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.

Journal: Blood advances

Published: April 18, 2024

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.

Journal: Blood

Published: November 20, 2023

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia.

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia.

Journal: Blood advances

Published: November 20, 2023

SEQ-ing the genetic constellation of acute lymphoblastic leukemia.

SEQ-ing the genetic constellation of acute lymphoblastic leukemia.

Journal: Haematologica

Published: November 20, 2023

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.

Journal: Research square

Published: July 28, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026